Catalyst Wire Dossier Catalyst Wire Dossier

NORLIQVA

AMLODIPINE · CMP Pharma, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NORLIQVA, covering 2022-02-24 to 2026-02-02. Get the full timeline:

Most recent: FDA Approved: NORLIQVA — Supplemental Application (CMP Pharma, Inc.)

See pricing